Loading
Iterative Health
Iterative Health is a healthcare technology and services company based in Cambridge, Massachusetts, with an additional office in New York City. Founded in 2017 by Jonathan Ng, the company focuses on applying artificial intelligence and computer vision to gastroenterology. Its mission is to enhance patient outcomes by speeding up the development and access to new treatments for gastrointestinal diseases, including colorectal cancer and inflammatory bowel disease. The company offers a range of services, including AI-driven clinical trial optimization, management of a global network of clinical research sites, and standardized disease severity assessments. Iterative Health's product lineup features the SKOUT polyp detection system, which aids gastroenterologists in identifying polyps during colonoscopies, and a proprietary AI platform that analyzes endoscopic images to improve diagnostic accuracy. With significant funding and strategic acquisitions, Iterative Health is positioned as a leader in the HealthTech sector, serving pharmaceutical companies, clinical research organizations, and healthcare systems.
Funding
Every round, secondary, debt facility or acquisition involving Iterative Health that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$4M